Focus: Opko Health is a public diagnostics and therapeutics company headquartered in Miami with diversified operations across infectious diseases, vaccines, and specialized therapeutics. The company operates as a mid-cap biopharmaceutical player with $863M in FY2025 revenue.
Profile data last refreshed 22h ago · AI intelligence enriched 2mo ago
No open roles listed right now. Follow Opko Health to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Opko Health's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Help build intelligence for Opko Health
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going? - TradingView
OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going? TradingView
OPKO Health, Inc. Discloses Investment in Cocrystal Pharma with 29.6% Stake - TradingView
OPKO Health, Inc. Discloses Investment in Cocrystal Pharma with 29.6% Stake TradingView
Cocrystal Pharma announces $5M investment from Opko Health - TipRanks
Cocrystal Pharma announces $5M investment from Opko Health TipRanks
OPKO Health Boosts Stake in Cocrystal Pharma Financing - TipRanks
OPKO Health Boosts Stake in Cocrystal Pharma Financing TipRanks
Cocrystal Pharma Raises $5 Million in Private Placement With OPKO Health at $0.9134/Share - TradingView
Cocrystal Pharma Raises $5 Million in Private Placement With OPKO Health at $0.9134/Share TradingView
Cocrystal Pharma (NASDAQ: COCP) secures $5M investment from OPKO Health - stocktitan.net
Cocrystal Pharma (NASDAQ: COCP) secures $5M investment from OPKO Health stocktitan.net
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Recent peer-reviewed publications with author affiliations at this company
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study.
MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumors.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo